Anzeige
Mehr »
Login
Freitag, 27.09.2024 Börsentäglich über 12.000 News von 691 internationalen Medien
Jetzt ist die Zeit, um in unterbewertete Goldaktien mit MEGA-Hebel zu investieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
309 Leser
Artikel bewerten:
(1)

Data Bridge Market Research: Lower Back Pain Market to Observe Utmost Growth of USD 13421.46 Million by 2029, Size, Share, Trends, Key Drivers, Development Trends and Industry Growth Outlook

VANCOUVER, BC, Oct. 13, 2022 /PRNewswire/ -- Recent study report released by Data Bridge Market research titled "Lower Back Pain Market" guarantees one will remain better informed than the competition. This Lower Back Pain market research report assists business in every sphere of trade to take superior decisions, to tackle the toughest business questions and diminish the risk of failure. The market data provided in the Lower Back Pain report helps to discover diverse market opportunities present worldwide for Lower Back Pain industry. A proficient team works meticulously with their potential capabilities to generate this finest Lower Back Pain market research report. By applying best-practice models and research methodologies, complete market analysis is performed in this report to make sure that the report provides accurate market segmentation and insights for the success of client's business.

Data_Bridge_Market_Research_Logo

Data Bridge Market Research analyses that the lower back pain market which was USD 8,812.01 million in 2021, would rocket up to USD 13421.46 million by 2029, and is expected to undergo a CAGR of 5.40% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Grab Sample Copy of Lower Back Pain Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lower-back-pain-market

Nearly everyone has experienced lower back discomfort at some point. Basically, it is a sort of muscle tension, pain, or rigidity that is present above the gluteal sulcus and below the bottom margin of the rib cage. It may be brought on by a strain (injury) to the back's muscles or tendons, arthritis, structural issues, or disc injuries. There are three different types of low back pain: acute, subacute, and chronic.

Acute low back pain can be treated for the underlying reason or the initial damage, but chronic low back pain must last for 12 weeks or more. Chronic low back pain is lower back discomfort that lasts longer than three months. This condition can be caused by an injury, illness, or stress on various body parts. The pain can vary greatly and manifest as bone pain, muscle pain, or nerve pain.

The primary growth drivers for the chronic lower back pain market are an increase in the frequency of nerve instances and an increase in the senior population. For instance, the National Institute of Neurological disorders and stroke reports that roughly 80% of adults have this type of low back discomfort at some point in their lives. Inactivity, expanding healthcare awareness in developed and developing nations, and rising consumer disposable income are further factors anticipated to promote market expansion

Some of the major players operating in the Lower Back Pain market are:

  • Pfizer Inc (U.S.)
  • Johnson & Johnson Private Limited (U.S.)
  • Sanofi (France)
  • Endo Pharmaceuticals Inc. (Ireland)
  • Merck & Co Inc. (U.S.)
  • Dr. Reddy's Laboratories Ltd. (India)
  • Vertebral Technologies, Inc. (U.S.)
  • Medtronic (Ireland)
  • Boston Scientific Corporation (U.S.)
  • BioWave Corporation
  • Koninklijke Philips N.V. (Netherlands)
  • Astellas Pharma Inc. (Japan)
  • SpineThera Inc. (U.S.)
  • CELGENE CORPORATION (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)

Get Detailed Research Report to Understand More @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-lower-back-pain-market

The Analysis Objectives Of The Report Are:

  • To know this Lower Back Pain Market size by pinpointing its sub-sections
  • To investigate the sum and estimation of this Market, contingent upon key areas
  • To consider the significant players and investigate their development plans
  • To investigate this Market concerning development patterns, possibilities, and furthermore their interest in the whole area
  • To analyze this market size (volume and worth) from the organization, basic locales/nations, items and application, foundation data
  • Essential overall this Market fabricating organizations, to indicate, explain, and examine the item deals sum, worth and piece of the pie, market contention scene, SWOT investigation, and improvement plans for future.
  • To analyze serious advancements, for example, extensions, courses of action, new item dispatches, and acquisitions available.

Market Dynamics: Lower Back Pain Market

  • Increase in nerve cases

Demand for the lower back pain market is anticipated to be driven by an inactive lifestyle and an increase in nerve cases. The increased use of novel antidepressants and the rising elderly population are additional significant factors driving the market's expansion. Within the forecast period, the market is expected to experience new, attractive growth prospects due to rising research and development, particularly in the area of lower back pain.

  • Rise in anti-inflammatory medications

Anti-inflammatory medications' negligible adverse effects are encouraging a rise in their use as painkillers. The effectiveness of pharmaceuticals like diclofenac, ibuprofen, and naproxen as non-steroidal anti-inflammatory treatments is aiding the industry's growth. Additionally, the lower doses of these medications are commonly accessible without a doctor's prescription. The market for lower back pain is anticipated to rise as a result of market participants' efforts to create novel NSAIDs that would lessen patients' pain.

  • Rising number of individuals

The expansion of the market is being aided by the rising number of individuals in the area who suffer from persistent lower back pain. The market growth for chronic lower back pain treatment in North America is quickening due to rising healthcare spending by the populace and the presence of cutting-edge healthcare infrastructure. In the upcoming years, it is projected that growing research efforts to identify the root causes of chronic lower back pain and create better treatment alternatives will spur market expansion.

Consider Data Bridge Market Research for this Report which would Help Impact Your Revenues Positively

  • This study offers the latest product news, trends, and updates from the industry's leading players who have leveraged their market position.
  • It also offers strategic plans and standards to arrive at informed business decisions adopted by the main players, thereby advocating your go to market strategies.
  • In addition, it offers insights into the dynamics of customer behaviour that can help the organization better curate market strategies
  • Usage of exclusive tailor-made tools along with primary research, secondary research and our in-house data model helps us in extracting the exact market numbers
  • Mapping the customer in 3P grid comprising of Purpose, Planning and Positioning, thereby delivering a solution by keeping the prospecting client at the sweet spot
  • The market research report includes all of the market's valuable elements, such as sales growth, product pricing & analysis, growth opportunities, and recommendations for addressing market challenges
  • The report covers all the primary mergers & acquisitions, alliances, and collaborations that have generated additional opportunities for market players or in some cases, challenges

To Gain More Insights about this Research, Visit @ https://www.databridgemarketresearch.com/reports/global-lower-back-pain-market

Key Industry Segmentation: Lower Back Pain Market

By Disease Type

  • Acute
  • Sub-Acute
  • Chronic

By Type

  • Diagnosis
  • Treatment

By End User

  • Hospitals
  • Orthopaedic Clinics
  • Ambulatory Surgery Centres
  • Others

By Distribution Channel

  • Direct
  • Retail

Regional Analysis/Insights: Lower Back Pain Market

The countries covered in the lower back pain market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the lower back pain market due to increased awareness over the availability of different treatment procedures.

Asia-Pacific is anticipated to have a fastest growth rate in the forecast period of 2022 to 2029 due to the rapidly growing expenditure on healthcare facilities by government and increasing geriatric population.

Table of Contents:

1. Introduction

2. Market Segmentation

3. Executive Summary

4. Premium Insights

5. Global Lower Back Pain Market: Regulations

6. Market Overview

7. Global Lower Back Pain Market, By Component

8. Global Lower Back Pain Market, By Gene Type

9. Global Lower Back Pain Market, By Gene Synthesis Type

10. Global Lower Back Pain Market, By Application

11. Global Lower Back Pain Market, By Method

12. Global Lower Back Pain Market, By End User

13. Global Lower Back Pain Market, By Distribution Channel

14. Global Lower Back Pain Market, By Region

15. Global Lower Back Pain Market: Company Landscape

16. SWOT Analyses

17. Company Profile

18. Questionnaires

19. Related Reports

To Check the Complete Table Of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-lower-back-pain-market

Explore More Reports:-

Pain Management Devices Market, By Type (Electrical Stimulators, Ablation Devices, Analgesic Infusion Pumps, Neurostimulation), Applications (Musculoskeletal Pain, Facial Pain and Migraine, Others), Mode of Purchase (Over-the-Counter (OTC) Devices, Prescription-Based Devices), End User (Medical Devices Manufacturing Companies and Academic and Research Organizations), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/pain-management-devices-market

Cold Pain Therapy Market By Product (OTC-based Products and Prescription Based Products), Application (Musculoskeletal Disorder, Sport Medicine, Post-Operative, Post-trauma and Physical Therapy), Therapy type (Icepack Therapy, Chamber Therapy and Cryosurgery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-cold-pain-therapy-market

Pain Relief Therapy Market, By Products (Prescription based products, OTC-based products {Pharmaceuticals, Medical Devices), Mode of Purchase (Over-The-Counter, Prescribed), Application (Musculoskeletal Disorder, Sport Medicine, Post-operative, Post-trauma, Physical Therapy), End-User (Hospitals, Clinics, Ambulatory Centers, Physiotherapy Centers, Homecare Settings) https://www.databridgemarketresearch.com/reports/global-pain-relief-therapy-market

Veterinary Pain Management Market, By Drug Type (Opioids, Morphine, Hydromorphone, Codeine, a2-adrenergic Agonists, Xylazine, Medetomidine, Local Anesthetics, Bupivacaine, Lidocaine, Chloroprocaine, Nonsteroidal Anti-inflammatory Drugs (NSIDs), Etodolac, Fentanyl, Meloxicam, Sedatives, Corticosteroids), Route of Administration (Oral Preparations, Parenteral Preparations), End-User (Veterinary Hospital Pharmacies, Retail Veterinary Pharmacies, Online Pharmacies), Distribution Channel (Veterinary Hospitals and Clinics, Pharmacies) https://www.databridgemarketresearch.com/reports/global-veterinary-pain-management-market

Non-Opioid Pain Treatment Market, By Products (Medical Cannabis, Menthol- Containing, Omega 3 Fatty Acid Containing, Botulinum Toxins, Capsaicin Derived), Therapeutic Applications (Orthopaedic and Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Other Pain), Drug Type (Acetaminophen, Non-steroidal Anti-inflammatory Drugs, Corticosteroids, Anticonvulsants, Serotoninnorepinephrine Reuptake Inhibitor Antidepressants), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies) https://www.databridgemarketresearch.com/reports/global-non-opioid-pain-treatment-market

Cancer Pain Market, By Drug Class (Opioids, NSAIDs, Others), Indication (Lung cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, Others), Route of Administration (Oral, Parenteral Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-cancer-pain-market

Neuropathic Pain Market, By Type (Spinal Cord Stimulation (SCS) Devices, External Peripheral Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation (Tens) Devices), Product Type (Rechargeable and Non-Rechargeable), Procedure (Invasive and Non-Invasive), Technology (Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation and Respiratory Electrical Stimulation), Modality (Stationary and Portable), Mode of Purchase (Over-the-Counter Devices and Prescription-Based Devices), Pain Type (Peripheral Neuropathy, Entrapment Neuropathy, Phantom Limb Neuropathy, Trigeminal Neuralgia, Post Herpetic Neuralgia (PHN), Post Traumatic Neuropathy, Foot Pain, Coccydynia), Indication (Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy, Others), End User (Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender, Third Party Distributor and Others), Country https://www.databridgemarketresearch.com/reports/global-neuropathic-pain-market

Ocular Pain Market, By Disease Type (Ocular Pain with Eye Diseases and Ocular Pain without Primary Eye Diseases), Type (Diagnosis and Treatment), Application (Conjunctivitis, Corneal Abrasion, Blepharitis, Sty, Iritis, Sinusitis, Migraines, Glaucoma, and Others), Route of Administration (Topical, Periocular, Intraocular, Oral and Others), Drug Type (Prescription and Over the Counter), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) https://www.databridgemarketresearch.com/reports/global-ocular-pain-market

Visceral Pain Market, By Drug Class (Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Others), Indications (Interstitial Cystitis, Crohn's, Irritable Bowel, Chronic Prostatitis, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) https://www.databridgemarketresearch.com/reports/global-visceral-pain-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

Logo: https://mma.prnewswire.com/media/1011053/Data_Bridge_Market_Research_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/lower-back-pain-market-to-observe-utmost-growth-of-usd-13421-46-million-by-2029--size-share-trends-key-drivers-development-trends-and-industry-growth-outlook-301648464.html

© 2022 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.